Wellnex to Dual List on the London Stock Exchange
Filed with ASX · · 3 pages · English
Summary by 6ix AI
The company has appointed Strand Hanson as its Financial Advisor and Barclay Pearce Capital along with Orana Corporation as joint-lead brokers for this listing. This dual listing aims to increase Wellnex's exposure to a broader pool of institutional investors and capitalize on existing distribution agreements in international markets.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Wellnex Life
- Reinstatement to Official Quotation
- Cleansing Prospectus
- UK Reg Approval for Paracetamol Soft Gel Liquid Analgesic
- Distribution Agreement Signed with Elysian
- Appendix 4C and Quarterly Report for Dec 2023 - Correction
Later from Wellnex Life
- Appendix 4C and Quarterly Report for Mar 2024 Quarter
- Launch of Additional Wakey Wakey Products
- Business Update
- Wellnex Re-engages CW NZ and Supplies First Pain Away Order
- Wellnex Launches Medicinal Cannabis Brand Wellness Life
Follow Wellnex Life into a list and get an email when it puts out news.
Follow Wellnex Life